Warren Buffett steps back this week as Berkshire Hathaway enters a new era

Berkshire Hathaway begins a new era as Greg Abel assumes operational control of the conglomerate while Warren Buffett remains chairman; Berkshire’s recent pace has slowed amid size constraints and the fall acquisition of OxyChem for $9.7 billion is unlikely to materially move results. Federal Reserve minutes showed a close, 9-3 decision to cut policy rates by 25 bps to about 3.6%, with two officials preferring no cut and one favoring a 50-bp cut, highlighting committee divisions exacerbated by delayed economic data from the government shutdown. In corporate M&A and tech, Meta reportedly paid north of $2 billion for AI startup Manus, which has crossed $100 million in ARR, while the US/Canada box office was tepid at $8.76 billion through Dec. 28 (up 1.6% YoY) as AMC shares plunged roughly 60% this year.

Analysis

Market structure: Meta (META) is the clear near-term winner — Manus brings a ~$100m ARR asset and reported ~$2bn price that accelerates Meta’s enterprise and consumer AI roadmap, likely lifting AI multiple re-ratings in 6–18 months. Berkshire (BRK.B) faces limited immediate disruption because Buffett stays as chairman and Abel has managed non‑insurance ops since 2018; the $9.7bn OxyChem deal is earnings‑neutral against a >$600bn market cap, so expect muted share reaction. Movie exhibitors (AMC) and legacy studio economics (WBD) remain losers as franchises and streaming M&A uncertainty compress theatrical leverage and box‑office upside; expect revenue pressure for exhibitors over the next 12–24 months.

Risk assessment: Tail risks include a governance shock at Berkshire if Abel deviates materially from Buffett’s capital allocation (low probability, high impact) and regulatory scrutiny on Manus given China links (mid probability, high impact). Macro risk: the Fed’s split view leaves a 25–75 bps swing plausible over 12 months — a reacceleration of inflation would compress growth multiples by 10–20%. Hidden dependencies: Meta’s monetization depends on ad demand and enterprise uptake; Netflix’s theatrical stunts may be noise rather than durable revenue.

Trade implications: Direct plays: size risk‑controlled longs in META (2–3% NAV) and BRK.B (1–2% NAV) for 6–18 months; shorts in AMC (1% NAV) and selected legacy media (WBD 1% NAV) as a 6–12 month hedge. Options: buy 3–6 month META call spreads (5–15% OTM) to cap premium; buy 3–9 month AMC put spreads to limit squeeze risk. Rotate 5–10% from cyclical leisure/media into large‑cap AI/tech and defensive financials if market breadth narrows.

Contrarian angles: The market may overestimate governance risk at Berkshire — Buffett’s daily presence and Abel’s track record argue against immediate large divestitures, so a BRK.B dip could be buying opportunity under 5% drawdown. Conversely, META’s price may understate enterprise AI revenue optionality; if Manus scales to $1bn ARR in 24 months, upside multiples could expand >20%. Beware shorting AMC: meme‑squeeze dynamics remain a persistent stop‑loss risk even if fundamentals deteriorate.

Key Decisions for Investors

• Establish a 2–3% NAV long position in META within 2–6 weeks via outright shares or a 3–6 month call spread 5–15% OTM; target 15–25% upside in 12 months, trim to half if META reports revenue guidance miss >5%.
• Initiate a 1% NAV short in AMC (equity or buy 3–9 month put spread) sizing to limit drawdown; target 30–70% downside over 6–12 months, cover if two consecutive quarters show domestic box‑office growth >5% QoQ or a material debt refinancing is announced.
• Add 1–2% NAV long BRK.B as defensive governance exposure, hold 12–24 months; increase position if Berkshire announces buybacks >$5bn/year or insider purchases by senior managers within 6 months.
• Implement a pair trade: long NFLX 1% NAV vs short WBD 1% NAV for 6–12 months to play streaming resilience vs legacy studio/M&A uncertainty; unwind if a binding merger agreement clears antitrust review or if Netflix’s theatrical+streaming revenue mix guidance improves >3% YoY.
• Allocate 1–2% NAV to options hedges: buy META 3–6 month call spreads (caps premium) and buy AMC 3–9 month put spreads to express asymmetric upside in AI and finite downside with controlled squeeze risk.